Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.

被引:4
|
作者
Araujo, Haniel Alves
Venchiarutti Moniz, Camila Motta
Melro Braghiroli, Oddone Freitas
Mak, Milena Perez
Uratani, Lucas Fernando
Tiecher, Ricardo Dahmer
Moraes, Priscila Muniz
Barbosa, Ingrid
De Camargo, Veridiana Pires
Freitas Melro Braghiroli, Maria Ignez
Castro, Gilberto
Hoff, Paulo Marcelo
Diz, Maria Del Pilar
机构
[1] Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[2] Inst DOr Pesquisa & Ensino, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sao Paulo, Brazil
关键词
D O I
10.1200/JCO.2021.39.15_suppl.2652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2652
引用
收藏
页数:2
相关论文
共 50 条
  • [1] PRESCRIBING PATTERNS OF PROTON PUMP INHIBITORS IN PATIENTS WITH LUNG CANCER TREATED WITH IMMUNOTHERAPY
    Japelj, Nusa
    Jazbar, Janja
    Mozek, Tjasa
    Knez, Lea
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2024, 20 (12):
  • [2] Proton Pump Inhibitors Worsen Colorectal Cancer Outcomes in Patients Treated with Bevacizumab
    Wu, Chin-Chia
    Fang, Chuan-Yin
    Chiou, Wen-Yen
    Chen, Pei-Tsen
    Hsu, Ta-Wen
    Hung, Shih-Kai
    Liao, Yu-Tso
    Hung, Chuan-Sheng
    Tsai, Jui-Hsiu
    CANCERS, 2024, 16 (19)
  • [3] Clinical outcomes in COVID-19 patients with cancer who are treated with chemo- or immunotherapy.
    Hatic, Haris
    Jung, Jenny B.
    Hearld, Kristine Ria
    Deshane, Jessy
    Das, Devika Govind
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18699 - E18699
  • [4] The Impact of Concomitant Proton Pump Inhibitors Therapy on Clinical Outcome of Cancer Patients Treated With Immune Checkpoint Inhibitors A Meta-analysis
    Cao, Xing
    Wang, Yafei
    Huang, Wei
    Li, Panyun
    Guo, Chongjie
    Li, Yuhui
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (04): : 142 - 149
  • [5] Association of proton pump inhibitors with survival in Veterans with non-small cell lung cancer receiving immunotherapy.
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David
    Giuste, Felipe
    Burns, Abigail
    Sebastian, Nikhil
    Ramalingam, Selvi
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas
    Moghanaki, Drew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
    Elkrief, A.
    Derosa, L.
    Kroemer, G.
    Zitvogel, L.
    Routy, B.
    ANNALS OF ONCOLOGY, 2019, 30 (10) : 1572 - 1579
  • [7] Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
    Del Re, Marzia
    Crucitta, Stefania
    Omarini, Claudia
    Bargagna, Irene
    Mongillo, Marta
    Palleschi, Michela
    Stucci, Stefania
    Meattini, Icro
    D'Onofrio, Raffaella
    Lorenzini, Giulia
    Biondani, Pamela
    De Giorgi, Ugo
    Porta, Camillo
    Livi, Lorenzo
    Natalizio, Salvatore
    Fontana, Andrea
    Giontella, Elena
    Angelini, Lucia
    Fogli, Stefano
    Danesi, Romano
    BREAST, 2022, 66 : 157 - 161
  • [8] Do Proton Pump Inhibitors Impact Clinical Outcomes in Staphylococcus Aureus Bacteremia?
    Caffrey, Aisling R.
    Timbrook, Tristan T.
    Sakoulas, George
    LaPlante, Kerry L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 469 - 470
  • [9] Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience
    Kitpanit, S.
    Lee, A.
    Fan, D.
    Fan, M.
    Wang, H.
    Mohamed, N.
    Spielsinger, D.
    Gelblum, D.
    Sherman, E.
    Dunn, L.
    Boyle, J. O.
    Wong, R. J.
    Cohen, M.
    Kang, J. J.
    Tsai, C. J.
    McBride, S.
    Zakeri, K.
    Chen, L.
    Yu, Y.
    Riaz, N.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1152 - 1153
  • [10] Impact of proton pump inhibitors and antibiotics on efficacy of nivolumab in patients with R/M HNSCC
    Wada, Akihisa
    Enokida, Tomohiro
    Okano, Susumu
    Sato, Masanobu
    Tanaka, Hideki
    Ueda, Yuri
    Fujisawa, Takao
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tahara, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S469 - S469